Hydroxyurea therapy reduces the hypercoagulability state in a sickle cell mouse model (2013)
- Authors:
- Colella, Marina Pereira - Universidade Estadual de Campinas (UNICAMP)
- Almeida, Camila Bononi - Universidade Estadual de Campinas (UNICAMP)
- Conran, Nicola - Universidade Estadual de Campinas (UNICAMP)
- Pallis, Flavia Rubia - Universidade Estadual de Campinas (UNICAMP)
- Franco-Penteado, Carla F. - Universidade Estadual de Campinas (UNICAMP)
- Bizzacchi, Joyce Maria Annicchino - Universidade Estadual de Campinas (UNICAMP)
- Costa, Fernando Ferreira - Universidade Estadual de Campinas (UNICAMP)
- Paula, Erich Vinicius de - Universidade Estadual de Campinas (UNICAMP)
- Saad, Sara Teresinha Ollala - Universidade Estadual de Campinas (UNICAMP)
- Traina, Fabíola
- Autor USP: TRAINA, FABÍOLA - FMRP
- Unidade: FMRP
- Subjects: ANEMIA FALCIFORME; INFLAMAÇÃO; TRANSTORNOS DA COAGULAÇÃO SANGUÍNEA
- Language: Inglês
- Imprenta:
- Publisher place: New Orleans
- Date published: 2013
- Source:
- Conference titles: Annual Meeting and Exposition of American Society of Hematology (ASH)
-
ABNT
COLELLA, Marina Pereira et al. Hydroxyurea therapy reduces the hypercoagulability state in a sickle cell mouse model. 2013, Anais.. New Orleans: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, 2013. Disponível em: https://ash.confex.com/ash/2013/webprogram/Paper59787.html. Acesso em: 29 dez. 2025. -
APA
Colella, M. P., Almeida, C. B., Conran, N., Pallis, F. R., Franco-Penteado, C. F., Bizzacchi, J. M. A., et al. (2013). Hydroxyurea therapy reduces the hypercoagulability state in a sickle cell mouse model. In Abstracts, Program and Personal Scheduler. New Orleans: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Recuperado de https://ash.confex.com/ash/2013/webprogram/Paper59787.html -
NLM
Colella MP, Almeida CB, Conran N, Pallis FR, Franco-Penteado CF, Bizzacchi JMA, Costa FF, Paula EV de, Saad STO, Traina F. Hydroxyurea therapy reduces the hypercoagulability state in a sickle cell mouse model [Internet]. Abstracts, Program and Personal Scheduler. 2013 ;[citado 2025 dez. 29 ] Available from: https://ash.confex.com/ash/2013/webprogram/Paper59787.html -
Vancouver
Colella MP, Almeida CB, Conran N, Pallis FR, Franco-Penteado CF, Bizzacchi JMA, Costa FF, Paula EV de, Saad STO, Traina F. Hydroxyurea therapy reduces the hypercoagulability state in a sickle cell mouse model [Internet]. Abstracts, Program and Personal Scheduler. 2013 ;[citado 2025 dez. 29 ] Available from: https://ash.confex.com/ash/2013/webprogram/Paper59787.html - FMNL1 is downregulated in myelodysplastic syndromes and is involved in megakaryocytic differentiation
- Increased inflammatory markers and their correlations to clinical complications in hemoglobin SC disease
- YAP1 expression in myelodysplastic syndromes and acute leukemias. [Carta]
- ANKHD1, a novel component of the Hippo signaling pathway, promotes YAP1 activation and cell cycle progression in prostate cancer cells
- Abnormal Hedgehog pathway in myelodysplastic syndrome and its impact on patients' outcome. [Carta]
- Key endothelial cell angiogenic mechanisms are stimulated by the circulating milieu in sickle cell disease and attenuated by hydroxyurea
- IRS2 silencing increases apoptosis and potentiates the effects of ruxolitinib in JAK2V617F-positive myeloproliferative neoplasms
- Padronização da investigação laboratorial de anticorpos dirigidos contra fármacos em doadores de sangue e pacientes com anemia hemolítica imune
- Differential profile of PIP4K2A expression in hematological malignancies
- Hedgehog pathway is deregulated in myelodysplastic syndrome progenitor bone marrow cells
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
